Pediatrix Medical Group, Inc.MDEarnings & Financial Report
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
MD Q4 FY2025 Key Financial Metrics
Revenue
$493.8M
Gross Profit
N/A
Operating Profit
$48.8M
Net Profit
$33.7M
Gross Margin
N/A
Operating Margin
9.9%
Net Margin
6.8%
YoY Growth
-1.7%
EPS
$0.40
Pediatrix Medical Group, Inc. Q4 FY2025 Financial Summary
Pediatrix Medical Group, Inc. reported revenue of $493.8M (down 1.7% YoY) for Q4 FY2025, with a net profit of $33.7M (up 10.5% YoY) (6.8% margin).
Key Financial Metrics
| Total Revenue | $493.8M |
|---|---|
| Net Profit | $33.7M |
| Gross Margin | N/A |
| Operating Margin | 9.9% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
Pediatrix Medical Group, Inc. Q4 FY2025 revenue of $493.8M breaks down across 3 segments, led by Health Care Patient Service at $421.6M (85.4% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Health Care Patient Service | $421.6M | 85.4% |
| Hospitals Contracts | $70.0M | 14.2% |
| Other | $2.2M | 0.5% |
Pediatrix Medical Group, Inc. Revenue by Segment — Quarterly Trend
Pediatrix Medical Group, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Health Care Patient Service and Hospitals Contracts) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Health Care Patient Service | $421.6M | $422.2M | $397.4M | $389.4M |
| Hospitals Contracts | $70.0M | $67.7M | $68.2M | $65.2M |
| Other | $2.2M | $3.0M | $3.2M | $3.8M |
Pediatrix Medical Group, Inc. Annual Revenue by Year
Pediatrix Medical Group, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.9B).
Pediatrix Medical Group, Inc. Quarterly Revenue & Net Profit History
Pediatrix Medical Group, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $493.8M | -1.7% | $33.7M | 6.8% |
| Q3 FY2025 | $492.9M | -3.6% | $71.7M | 14.5% |
| Q2 FY2025 | $468.8M | -7.0% | $39.3M | 8.4% |
| Q1 FY2025 | $458.4M | -7.4% | $20.7M | 4.5% |
| Q4 FY2024 | $502.4M | +1.2% | $30.5M | 6.1% |
| Q3 FY2024 | $511.2M | +0.9% | $19.4M | 3.8% |
| Q2 FY2024 | $504.3M | +0.7% | $-153.0M | -30.3% |
| Q1 FY2024 | $495.1M | +0.8% | $4.0M | 0.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $495.1M | $504.3M | $511.2M | $502.4M | $458.4M | $468.8M | $492.9M | $493.8M |
| YoY Growth | 0.8% | 0.7% | 0.9% | 1.2% | -7.4% | -7.0% | -3.6% | -1.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.17B | $2.00B | $2.08B | $2.15B | $1.99B | $2.10B | $2.20B | $2.25B |
| Liabilities | $1.31B | $1.29B | $1.34B | $1.39B | $1.20B | $1.27B | $1.31B | $1.38B |
| Equity | $856.2M | $706.5M | $732.5M | $764.9M | $789.2M | $833.8M | $890.7M | $865.9M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-125.2M | $107.0M | $91.8M | $133.0M | $-117.5M | $137.2M | $137.3M | $114.1M |